Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$173M |
| 2 |
Amcor
AMCR
|
+$138M |
| 3 |
Microsoft
MSFT
|
+$99.3M |
| 4 |
Amazon
AMZN
|
+$97.5M |
| 5 |
Intel
INTC
|
+$96.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$126M |
| 2 |
Alexandria Real Estate Equities
ARE
|
+$123M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$58.6M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$45.7M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.86% |
| 2 | Financials | 14.49% |
| 3 | Healthcare | 12.78% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Alaunos Therapeutics
TCRT
$4.86M
| $5.24M | ﹤0.01% |
5,991
+425
| +8% | +$292K |
|
|
NE
1952
DELISTED
Noble Corporation
NE
| $5.23M | ﹤0.01% |
2,794,318
+342,664
| +14% | +$806K |
|
|
DPLO
1953
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $5.21M | ﹤0.01% |
856,069
+198,315
| +30% | +$1.05M |
|
1954
CareDx
CDNA
$2.45B
| $5.21M | ﹤0.01% |
144,823
+10,142
| +8% | +$325K |
|
1955
Team
TISI
$101M
| $5.2M | ﹤0.01% |
33,907
+610
| +2% | +$98.4K |
|
|
LABL
1956
DELISTED
Multi-Color Corp
LABL
| $5.18M | ﹤0.01% |
103,704
+12,479
| +14% | +$623K |
|
|
AGS
1957
DELISTED
PlayAGS
AGS
| $5.17M | ﹤0.01% |
265,723
+125,034
| +89% | +$2.69M |
|
1958
Yeti Holdings
YETI
$3.44B
| $5.15M | ﹤0.01% |
177,984
+82,582
| +87% | +$2.38M |
|
1959
Pathward Financial
CASH
$1.79B
| $5.15M | ﹤0.01% |
183,468
+25,054
| +16% | +$637K |
|
1960
Allogene Therapeutics
ALLO
$683M
| $5.14M | ﹤0.01% |
191,343
+38,579
| +25% | +$1.07M |
|
|
FTR
1961
DELISTED
Frontier Communications Corp.
FTR
| $5.13M | ﹤0.01% |
2,933,234
+741,960
| +34% | +$1.51M |
|
|
GTHX
1962
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $5.1M | ﹤0.01% |
166,430
+26,079
| +19% | +$549K |
|
|
MOBL
1963
DELISTED
MobileIron, Inc.
MOBL
| $5.1M | ﹤0.01% |
822,969
+461,363
| +128% | +$2.61M |
|
|
LMNX
1964
DELISTED
Luminex Corp
LMNX
| $5.08M | ﹤0.01% |
245,979
-24,249
| -9% | -$533K |
|
|
VIVO
1965
DELISTED
Meridian Bioscience Inc
VIVO
| $5.07M | ﹤0.01% |
426,346
-129,628
| -23% | -$1.56M |
|
|
OLP
1966
One Liberty Properties
OLP
$537M
| $5.06M | ﹤0.01% |
174,806
-46,340
| -21% | -$1.34M |
|
1967
Amneal Pharmaceuticals
AMRX
$6.02B
| $5.06M | ﹤0.01% |
705,657
+33,072
| +5% | +$338K |
|
|
CRZO
1968
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $5.05M | ﹤0.01% |
503,773
+10,744
| +2% | +$124K |
|
1969
PJT Partners
PJT
$4.57B
| $5.04M | ﹤0.01% |
124,430
+11,217
| +10% | +$457K |
|
|
CARB
1970
DELISTED
Carbonite Inc
CARB
| $5.01M | ﹤0.01% |
192,401
+5,510
| +3% | +$135K |
|
|
ALDR
1971
DELISTED
Alder Biopharmaceuticals
ALDR
| $5M | ﹤0.01% |
425,222
+43,849
| +11% | +$531K |
|
|
WLH
1972
DELISTED
WILLIAM LYON HOMES
WLH
| $4.98M | ﹤0.01% |
273,128
+37,516
| +16% | +$676K |
|
|
RTEC
1973
DELISTED
Rudolph Technologies Inc
RTEC
| $4.96M | ﹤0.01% |
179,599
+1,752
| +1% | +$42.7K |
|
1974
Madrigal Pharmaceuticals
MDGL
$11.7B
| $4.96M | ﹤0.01% |
47,317
+2,427
| +5% | +$260K |
|
1975
MGP Ingredients
MGPI
$389M
| $4.96M | ﹤0.01% |
74,741
+600
| +0.8% | +$42.2K |
|
Similar funds
Charles Schwab's Q2 2019 Portfolio in Review
As of Q2 2019, Charles Schwab held 3,341 positions worth $164B, up 5.3% from $156B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Charles Schwab's Q2 2019 filing shows 147 new, 2,302 increased, 628 reduced and 129 closed positions. Its largest new stake was Dow Inc: 3,280,629 shares worth $162M. The largest sale was DuPont de Nemours, an estimated $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2019 buy was Dow Inc: 3,280,629 shares worth $162M.
- Charles Schwab added most to Microsoft in Q2 2019, an estimated $99.3M increase.
- Charles Schwab's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $126M.
- Charles Schwab fully exited China Mobile Limited in Q2 2019, selling an estimated $58.6M.
- Charles Schwab's ten largest holdings make up 15% of its $164B portfolio in Q2 2019.
- Charles Schwab opened 147 new positions and closed 129 in Q2 2019.
- Charles Schwab's portfolio value rose 5.3% quarter-over-quarter to $164B.
Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.